Evaluating two decision aids for Australian men to support informed choice about prostate cancer screening
Active, not recruiting
- Conditions
- prostate cancerinformed choiceoverdiagnosisPublic Health - Health promotion/educationCancer - Prostate
- Registration Number
- ACTRN12618001718235
- Lead Sponsor
- Sydney School of Public Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Male
- Target Recruitment
- 3000
Inclusion Criteria
Men eligible to participate if registered with the survey panel, accept an invitation to participate in the online questionnaire, and aged between 45 and 60 years, without a prostate cancer diagnosis.
Exclusion Criteria
Previous prostate cancer diagnosis
Outside 45-60 years age bracket
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with informed decision-making in prostate cancer screening trials like ACTRN12618001718235?
How do decision aids in ACTRN12618001718235 reduce overdiagnosis risks compared to standard PSA testing protocols?
What molecular pathways are targeted by prostate cancer screening strategies evaluated in this Australian trial?
Are there adverse events associated with prostate cancer screening decision aids in large-scale population studies?
How does ACTRN12618001718235 compare to other health promotion interventions for prostate cancer risk communication?